Catalyst Wire Dossier Catalyst Wire Dossier

Nafamostat

nafamostat mesylate
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Nafamostat, covering 2010-05-03 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) [Phase 2]

See pricing